Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab

DSpace/Manakin Repository

Biological Tipping Point in Patients with Atopic Dermatitis Treated with Different Dosing Intervals of Dupilumab
 
Dekkers, Coco; van der Wal, M Marlot; El Amrani, Mohsin; van Luin, Matthijs; Bakker, Daphne S; de Bruin-Weller, Marjolein; van Wijk, Femke
(2023) Journal of Investigative Dermatology, volume 143, issue 9, pp. 1822 - 1825.e3
(Comment)
Download/Full Text
Open Access version via Utrecht University Repository Publisher version
Version on publisher website for UU-students and staff
Version on publisher website
 
Keywords: Dermatology, Molecular Biology, Biochemistry, Cell Biology, Journal Article
DOI: https://doi.org/10.1016/j.jid.2023.03.1659
ISSN: 0022-202X
Publisher: Elsevier
Note: Funding Information: CD, MMVDW, MEA, MVL, DSB, MDBW, and FVW have made substantial contributions to conception and design, the acquisition of data, or the analysis and interpretation of data. All authors have been involved in drafting the manuscript or revising it critically and have given their final approval of the version to be published. Patients included in this manuscript participated in the BioDay registry sponsored by Sanofi Genzyme. Conceptualization: CD, MMVDW, DSB, MDBW, FVW; Formal Analysis: CD, MMVDW, MEA; Funding Acquisition: FVW, MDBW; Investigation: CD, MMVDW, MEA; Methodology: MMVDW, MEA; Resources: CD, MMVDW, MEA; Supervision: MDBW, FVW; Validation: FVW; Visualization: CD, MMVDW; Writing - Original Draft Preparation: CD, MMVDW; Writing - Review and Editing: MEA, MVL, DSB, MDBW, FVW
(Peer reviewed)